The Cigna Corp (CI)

$330.07

+6.68

(+2.07%)▲

Market is closed - opens 8 PM, 22 Nov 2024
star icon

Cigna Corp is a global health service company that provides medical, dental, and disability insurance plans.

Performance

  • $322.21
    $330.87
    $330.07
    downward going graph

    2.38%

    Downside

    Day's Volatility :2.62%

    Upside

    0.24%

    downward going graph
  • $253.95
    $370.83
    $330.07
    downward going graph

    23.06%

    Downside

    52 Weeks Volatility :31.52%

    Upside

    10.99%

    downward going graph

Returns

PeriodThe Cigna CorpSector (Health Care)S&P500
3 Months
-5.55%
-7.6%
5.3%
6 Months
-3.86%
-2.3%
11.2%
1 Year
12.88%
10.1%
30.4%
3 Years
52.87%
7.5%
26.0%

Highlights

Market Capitalization
89.7B
Book Value
$150.61
Dividend Share
5.43
Dividend Yield
1.74%
Earnings Per Share (EPS)
10.55
PE Ratio
30.57
PEG Ratio
0.77
Wall Street Target Price
399.003
Profit Margin
1.32%
Operating Margin TTM
2.74%
Return On Assets TTM
2.8%
Return On Equity TTM
7.61%
Revenue TTM
229.7B
Revenue Per Share TTM
808.02
Quarterly Revenue Growth YOY
28.000000000000004%
Gross Profit TTM
23.0B
EBITDA
8.6B
Diluted Eps TTM
10.55
Quarterly Earnings Growth YOY
-0.44
EPS Estimate Current Year
28.5
EPS Estimate Next Year
31.58
EPS Estimate Current Quarter
7.2
EPS Estimate Next Quarter
8.12

Analyst Recommendation

Buy
    81%Buy
    18%Hold
    0
    0%Sell
Based on 32 Wall street analysts offering stock ratings for The Cigna Corp(by analysts ranked 0 to 5 stars)
Based on 32 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
26
26
20
Hold
6
6
10
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 20.88%

Current $330.07
Target $399.00

Company Financials

FY18Y/Y Change
Revenue
48.6B
↑ 15.52%
Net Income
2.6B
↑ 17.88%
Net Profit Margin
5.43%
↑ 0.11%
FY19Y/Y Change
Revenue
153.7B
↑ 216.55%
Net Income
5.1B
↑ 93.55%
Net Profit Margin
3.32%
↓ 2.11%
FY20Y/Y Change
Revenue
160.6B
↑ 4.45%
Net Income
8.5B
↑ 65.71%
Net Profit Margin
5.27%
↑ 1.95%
FY21Y/Y Change
Revenue
174.3B
↑ 8.53%
Net Income
5.4B
↓ 36.51%
Net Profit Margin
3.08%
↓ 2.19%
FY22Y/Y Change
Revenue
180.6B
↑ 3.66%
Net Income
6.7B
↑ 24.84%
Net Profit Margin
3.71%
↑ 0.63%
FY23Y/Y Change
Revenue
195.2B
↑ 8.05%
Net Income
5.2B
↓ 22.97%
Net Profit Margin
2.65%
↓ 1.06%
Q2 FY23Q/Q Change
Revenue
48.6B
↑ 4.64%
Net Income
1.5B
↑ 15.23%
Net Profit Margin
3.0%
↑ 0.27%
Q3 FY23Q/Q Change
Revenue
49.0B
↑ 0.89%
Net Income
41.0M
↓ 97.19%
Net Profit Margin
0.08%
↓ 2.92%
Q4 FY23Q/Q Change
Revenue
51.1B
↑ 4.14%
Net Income
1.0B
↑ 2409.76%
Net Profit Margin
2.01%
↑ 1.93%
Q1 FY24Q/Q Change
Revenue
55.4B
↑ 8.49%
Net Income
-277.0M
↓ 126.92%
Net Profit Margin
-0.5%
↓ 2.51%
Q2 FY24Q/Q Change
Revenue
60.5B
↑ 9.12%
Net Income
1.5B
↓ 658.84%
Net Profit Margin
2.56%
↑ 3.06%
Q3 FY24Q/Q Change
Revenue
63.7B
↑ 5.32%
Net Income
86.0M
↓ 94.44%
Net Profit Margin
0.14%
↓ 2.42%
FY18Y/Y Change
Total Assets
153.2B
↑ 148.13%
Total Liabilities
112.2B
↑ 133.81%
FY19Y/Y Change
Total Assets
155.8B
↑ 1.66%
Total Liabilities
110.4B
↓ 1.57%
FY20Y/Y Change
Total Assets
155.5B
↓ 0.21%
Total Liabilities
105.1B
↓ 4.83%
FY21Y/Y Change
Total Assets
154.9B
↓ 0.36%
Total Liabilities
107.7B
↑ 2.51%
FY22Y/Y Change
Total Assets
143.9B
↓ 7.07%
Total Liabilities
99.0B
↓ 8.1%
FY23Y/Y Change
Total Assets
152.8B
↑ 6.13%
Total Liabilities
106.4B
↑ 7.51%
Q2 FY23Q/Q Change
Total Assets
150.1B
↑ 1.4%
Total Liabilities
104.5B
↑ 1.11%
Q3 FY23Q/Q Change
Total Assets
149.6B
↓ 0.27%
Total Liabilities
103.9B
↓ 0.62%
Q4 FY23Q/Q Change
Total Assets
147.9B
↓ 1.15%
Total Liabilities
101.6B
↓ 2.22%
Q1 FY24Q/Q Change
Total Assets
148.4B
↑ 0.35%
Total Liabilities
107.1B
↑ 5.44%
Q2 FY24Q/Q Change
Total Assets
150.9B
↑ 1.62%
Total Liabilities
109.3B
↑ 2.08%
Q3 FY24Q/Q Change
Total Assets
157.6B
↑ 4.5%
Total Liabilities
115.3B
↑ 5.5%
FY18Y/Y Change
Operating Cash Flow
3.8B
↓ 7.73%
Investing Cash Flow
-26.4B
↑ 1448.91%
Financing Cash Flow
23.5B
↓ 987.02%
FY19Y/Y Change
Operating Cash Flow
9.5B
↑ 151.59%
Investing Cash Flow
-734.0M
↓ 97.22%
Financing Cash Flow
-7.2B
↓ 130.56%
FY20Y/Y Change
Operating Cash Flow
10.4B
↑ 9.12%
Investing Cash Flow
3.0B
↓ 505.45%
Financing Cash Flow
-8.5B
↑ 18.73%
FY21Y/Y Change
Operating Cash Flow
7.2B
↓ 30.52%
Investing Cash Flow
-3.6B
↓ 221.34%
Financing Cash Flow
-8.2B
↓ 3.76%
FY22Y/Y Change
Operating Cash Flow
8.7B
↑ 20.37%
Investing Cash Flow
3.1B
↓ 185.79%
Financing Cash Flow
-11.2B
↑ 36.87%
Q2 FY23Q/Q Change
Operating Cash Flow
2.5B
↓ 50.44%
Investing Cash Flow
-414.0M
↓ 86.12%
Financing Cash Flow
-435.0M
↑ 1075.68%
Q3 FY23Q/Q Change
Operating Cash Flow
2.8B
↑ 13.4%
Investing Cash Flow
-4.7B
↑ 1043.48%
Financing Cash Flow
-2.6B
↑ 491.26%

Technicals Summary

Sell

Neutral

Buy

The Cigna Corp is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
The Cigna Corp
The Cigna Corp
0.99%
-3.86%
12.88%
52.87%
60.72%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
5.08%
14.7%
11.29%
37.24%
117.14%
Cvs Health Corporation
Cvs Health Corporation
-2.3%
-0.85%
-16.52%
-38.89%
-24.17%
Humana Inc.
Humana Inc.
12.82%
-17.34%
-42.03%
-32.01%
-13.15%
Elevance Health, Inc
Elevance Health, Inc
-5.87%
-27.15%
-15.54%
-5.23%
35.32%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
The Cigna Corp
The Cigna Corp
30.56
30.57
0.77
28.5
0.08
0.03
0.02
150.61
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
38.29
38.29
1.61
27.61
0.15
0.07
0.01
102.42
Cvs Health Corporation
Cvs Health Corporation
13.51
14.15
1.92
5.62
0.07
0.02
0.05
59.57
Humana Inc.
Humana Inc.
24.22
24.22
1.27
16.14
0.08
0.04
0.01
145.88
Elevance Health, Inc
Elevance Health, Inc
14.58
14.35
0.73
33.02
0.16
0.06
0.02
188.74
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
The Cigna Corp
The Cigna Corp
Buy
$89.7B
60.72%
30.56
1.32%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$545.0B
117.14%
38.29
3.64%
Cvs Health Corporation
Cvs Health Corporation
Buy
$70.5B
-24.17%
13.51
1.37%
Humana Inc.
Humana Inc.
Buy
$33.4B
-13.15%
24.22
1.18%
Elevance Health, Inc
Elevance Health, Inc
Buy
$92.9B
35.32%
14.58
3.69%

Insights on The Cigna Corp

  • Increasing Revenue

    Revenue is up for the last 9 quarters, 45.19B → 63.69B (in $), with an average increase of 4.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 1.54B → 86.0M (in $), with an average decrease of 94.4% per quarter

Institutional Holdings

  • Vanguard Group Inc

    9.38%

  • BlackRock Inc

    8.57%

  • FMR Inc

    5.12%

  • State Street Corp

    4.65%

  • T. Rowe Price Associates, Inc.

    4.46%

  • Morgan Stanley - Brokerage Accounts

    4.41%

Corporate Announcements

  • The Cigna Corp Dividends March,2024

    In the quarter ending March,2024. The Cigna Corp has declared dividend of $1.40

    Read More

Company Information

The Cigna Group is a global health services company. The Companys portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare.

Organization
The Cigna Corp
Employees
70325
CEO
Mr. David Michael Cordani
Industry
Health Services

FAQs